Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,683 | 19,866 | 17,785 | 24,806 | 30,634 |
| TOTAL | $13,846 | $20,530 | $18,761 | $25,285 | $31,395 |
| Non-Current Assets | |||||
| PPE Net | 376 | 419 | 339 | 365 | 331 |
| Other Non-Current Assets | 616 | 642 | 219 | 242 | 265 |
| TOTAL | $992 | $1,060 | $558 | $607 | $596 |
| Total Assets | $14,839 | $21,590 | $19,320 | $25,892 | $31,990 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,905 | 5,478 | 6,367 | 5,462 | 4,512 |
| Other current liabilities | N/A | 5,972 | N/A | N/A | N/A |
| TOTAL | $6,956 | $11,502 | $6,515 | $5,606 | $4,651 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 548 | 1,935 | 54 | 92 | 130 |
| TOTAL | $548 | $1,935 | $54 | $92 | $130 |
| Total Liabilities | $7,504 | $13,437 | $6,569 | $5,698 | $4,781 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 324 | 324 | 313 | 203 | 203 |
| Common Shares | 0 | 0 | 0 | 0 | 1 |
| Retained earnings | -188,080 | -159,990 | -172,284 | -164,473 | -157,038 |
| TOTAL | $7,335 | $8,153 | $12,751 | $20,194 | $27,209 |
| Total Liabilities And Equity | $14,839 | $21,590 | $19,320 | $25,892 | $31,990 |